AMD3100 Inhibits the Secretion of MMP-9 in Mesenchymal Stem Cells With Cancer-Associated Fibroblast-Like Phenotype, and Inhibits the Activation of PI3K/AKT Signaling Pathway in Acute Lymphoblastic Leukemia Cells. Here, AKT1 is linked to cancer.